Cardiac Science Corporation (NASDAQ: CSCX) is a global leader in developing, manufacturing and marketing diagnostic and therapeutic cardiology products and services that protect hearts and save lives.

Formed by the merger of Cardiac Science, Inc. and Quinton Cardiology Systems, Inc. on September 1, 2005, the company employs more than 550 people worldwide. Headquartered near Seattle, WA, the company also has operations in California, Wisconsin, China, Denmark and the United Kingdom.

The strategic benefits of the merger are significant — including substantial operational savings, stronger distribution networks, enhanced customer service and greater technology capabilities to support cutting-edge product development.

Three Trusted Brands, One New Company.
By leveraging the market leadership of its predecessor companies and their established brands — Burdick®, Powerheart®, and Quinton® — Cardiac Science Corporation is uniquely positioned to effectively address both established and emerging cardiology market segments.

A Broad Range of Cardiology Products and Services.
From individual devices designed to identify the early stages of heart disease—such as Electrocardiographs, Cardiac Stress Testing Systems, and Holter Monitors—to sophisticated systems that enable Cardiac Rehabilitation and Cardiology Data Management, as well as life-saving, innovative and patented automated external defibrillators (AEDs) for both medical and non-medical markets, Cardiac Science Corporation offers solutions across the entire continuum of cardiac care.

A variety of related products and supplies, as well as superior customer and technical support through a comprehensive portfolio of training, maintenance and service programs, are also available to accommodate diverse budgets and needs.